Literature DB >> 3513588

The effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome in preterm gestations with premature rupture of membranes.

W J Morales, N D Diebel, A J Lazar, D Zadrozny.   

Abstract

A prospective blinded randomized study was carried out to determine the effect of antepartum administration of dexamethasone on the incidence of respiratory distress syndrome in 250 patients with gestations between 28 and 33 weeks complicated by premature rupture of membranes. The incidence of respiratory distress syndrome was not lowered by the length of rupture of membranes in the 124 untreated patients. The overall incidence of respiratory distress syndrome was reduced from 51% to 25% by the administration of corticosteroids. Further, the dexamethasone-treated group had a statistical significant reduction in the incidence of intraventricular hemorrhage, total time of hospitalization, and average cost per patient. No statistical difference was encountered in the incidence of maternal or neonatal sepsis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3513588     DOI: 10.1016/0002-9378(86)90607-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Cost implications of different approaches to the prevention of respiratory distress syndrome.

Authors:  M Mugford; J Piercy; I Chalmers
Journal:  Arch Dis Child       Date:  1991-07       Impact factor: 3.791

2.  Premature rupture of membranes.

Authors:  A Akierman; S Iwanicki
Journal:  Can Fam Physician       Date:  1988-09       Impact factor: 3.275

Review 3.  Fetal drug therapy.

Authors:  M I Evans; P G Pryde; A Reichler; M Bardicef; M P Johnson
Journal:  West J Med       Date:  1993-09

Review 4.  Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.

Authors:  Devender Roberts; Julie Brown; Nancy Medley; Stuart R Dalziel
Journal:  Cochrane Database Syst Rev       Date:  2017-03-21

5.  Cost-effectiveness of antenatal corticosteroids and tocolytic agents in the management of preterm birth: A systematic review.

Authors:  Elizabeth Sebastian; Chloe Bykersma; Alexander Eggleston; Katherine E Eddy; Sher Ting Chim; Rana Islamiah Zahroh; Nick Scott; Doris Chou; Olufemi T Oladapo; Joshua P Vogel
Journal:  EClinicalMedicine       Date:  2022-06-03

6.  Mitogen-inducible gene-6 partly mediates the inhibitory effects of prenatal dexamethasone exposure on endochondral ossification in long bones of fetal rats.

Authors:  Xianrong Zhang; Yangfan Shang-Guan; Jing Ma; Hang Hu; Linlong Wang; Jacques Magdalou; Liaobin Chen; Hui Wang
Journal:  Br J Pharmacol       Date:  2016-06-02       Impact factor: 8.739

Review 7.  Steroid hormones and brain development: some guidelines for understanding actions of pseudohormones and other toxic agents.

Authors:  B S McEwen
Journal:  Environ Health Perspect       Date:  1987-10       Impact factor: 9.031

8.  Antenatal Corticosteroid Therapy Attenuates Angiogenesis Through Inhibiting Osteoclastogenesis in Young Mice.

Authors:  Yu Chai; Jianwen Su; Weisheng Hong; Runjiu Zhu; Caiyu Cheng; Lei Wang; Xianrong Zhang; Bin Yu
Journal:  Front Cell Dev Biol       Date:  2020-12-15

9.  Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.

Authors:  Emma McGoldrick; Fiona Stewart; Roses Parker; Stuart R Dalziel
Journal:  Cochrane Database Syst Rev       Date:  2020-12-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.